Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Hepatocellular 42Parkinson Disease 4, Autosomal Dominant Lewy Body 29Carcinoma, Renal Cell 26Endometrial Neoplasms 13Melanoma 10Neoplasms 8Uterine Cervical Neoplasms 7Cholangiocarcinoma 7Biliary Tract Neoplasms 7Liver Neoplasms 6Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neuroendocrine Tumors 5Triple Negative Breast Neoplasms 4Thyroid Neoplasms 4Ovarian Neoplasms 4Neoplasm Metastasis 4Esophageal Squamous Cell Carcinoma 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Thyroid Carcinoma, Anaplastic 3Recurrence 3Kidney Neoplasms 3Esophageal Neoplasms 3Diabetes Mellitus, Insulin-Dependent, 12 3Carcinoma, Adenoid Cystic 3Breast Neoplasms 3Brain Neoplasms 3Adenocarcinoma 3Vulvar Neoplasms 2

Interventions

Nivolumab 4Magnetic Resonance Spectroscopy 4Ipilimumab 3pembrolizumab 2cabozantinib 2aldesleukin 2Specimen Handling 2CTLA-4 Antigen 2Adoptive Transfer 2niraparib 1lenvatinib 1entinostat 1enfortumab vedotin 1dostarlimab 1cemiplimab 1bintrafusp alfa protein, human 1avelumab 1Psychiatric Nursing 1Platinum 1Physical Therapy Modalities 1Palliative Care 1Paclitaxel 1Gemcitabine 1Fluorodeoxyglucose F18 1FAPI-46 1Cisplatin 1CP protocol 1Biopsy 1BAY 1895344 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Penile Neoplasms × lenvatinib × 1 year × Clear all
NCT07384416 2026-05-08

QL1706 Plus Lenvatinib in Previously Treated Penile Cancer

Sun Yat-sen University

Phase 2 Recruiting
47 enrolled
Genitourinary

Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡